Tongli Haiyuan Biotechnology
About:
Tongli Haiyuan Biotechnology focuses on the R&D and production of GMP-grade core raw material reagents for upstream cell and gene therapy.
Website: http://www.seafrom.cn/
Top Investors: Fortune Venture Capital, Harvest Capital
Description:
Total Funding Amount:
90M CNY
Headquarters Location:
Daxing, Beijing, China
Founded Date:
2011-04-26
Contact Email:
3256528411(AT)qq.com
Founders:
Number of Employees:
101-250
Last Funding Date:
2023-03-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai